Literature DB >> 31968272

Duration of antibiotic therapy for Staphylococcus aureus bacteraemia: the long and the short of it.

E M Eichenberger1, V G Fowler2, T L Holland3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31968272      PMCID： PMC7278270          DOI： 10.1016/j.cmi.2020.01.003

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   13.310


× No keyword cloud information.
  28 in total

1.  Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review.

Authors:  I I Raad; M F Sabbagh
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

2.  Short-course therapy for catheter-associated Staphylococcus aureus bacteremia.

Authors:  W F Ehni; L B Reller
Journal:  Arch Intern Med       Date:  1989-03

3.  Relationship of staphylococcal tolerance, teichoic acid antibody, and serum bactericidal activity to therapeutic outcome in Staphylococcus aureus bacteremia.

Authors:  J J Rahal; Y K Chan; G Johnson
Journal:  Am J Med       Date:  1986-07       Impact factor: 4.965

4.  Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014.

Authors:  Michihiko Goto; Marin L Schweizer; Mary S Vaughan-Sarrazin; Eli N Perencevich; Daniel J Livorsi; Daniel J Diekema; Kelly K Richardson; Brice F Beck; Bruce Alexander; Michael E Ohl
Journal:  JAMA Intern Med       Date:  2017-10-01       Impact factor: 21.873

5.  Changing Characteristics of Staphylococcus aureus Bacteremia: Results From a 21-Year, Prospective, Longitudinal Study.

Authors:  Maria Souli; Felicia Ruffin; Seong-Ho Choi; Lawrence P Park; Shengli Gao; Nicholas Christopoulos Lent; Batu K Sharma-Kuinkel; Joshua T Thaden; Stacey A Maskarinec; Lisa Wanda; Jonathan Hill-Rorie; Bobby Warren; Brenda Hansen; Vance G Fowler
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

6.  Clinical identifiers of complicated Staphylococcus aureus bacteremia.

Authors:  Vance G Fowler; Maren K Olsen; G Ralph Corey; Christopher W Woods; Christopher H Cabell; L Barth Reller; Allen C Cheng; Tara Dudley; Eugene Z Oddone
Journal:  Arch Intern Med       Date:  2003-09-22

7.  Management of catheter-related Staphylococcus aureus bacteremia: when may sonographic study be unnecessary?

Authors:  C Pigrau; D Rodríguez; A M Planes; B Almirante; N Larrosa; E Ribera; J Gavaldà; A Pahissa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-06       Impact factor: 3.267

8.  Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.

Authors:  Feng-Yee Chang; James E Peacock; Daniel M Musher; Patricia Triplett; Brent B MacDonald; Joseph M Mylotte; Alice O'Donnell; Marilyn M Wagener; Victor L Yu
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

9.  Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.

Authors:  Achim J Kaasch; Gerd Fätkenheuer; Reinhild Prinz-Langenohl; Ursula Paulus; Martin Hellmich; Verena Weiß; Norma Jung; Siegbert Rieg; Winfried V Kern; Harald Seifert
Journal:  Trials       Date:  2015-10-09       Impact factor: 2.279

10.  Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.

Authors:  Louise Thorlacius-Ussing; Christian Østergaard Andersen; Niels Frimodt-Møller; Inge Jenny Dahl Knudsen; Jens Lundgren; Thomas Lars Benfield
Journal:  Trials       Date:  2019-05-02       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.